CoChat

The administration of l-thyroxine as soft gel capsule or liquid solution

Vita, Roberto, Fallahi, Poupak, Antonelli, Alessandro, Benvenga, Salvatore · 2014 · Expert Opinion on Drug Delivery
Cited by 93

The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.

Abstract

INTRODUCTION: Levothyroxine (l-T4) is the mainstay of treating hypothyroidism. The tablet is the traditional formulation of l-T4. Tablet l-T4 malabsorption results from either hindered gastric dissolution of the tablet or binding of l-T4 by sequestrants in the intestinal lumen. AREAS COVERED: This review provides an overview of the pharmacokinetics of l-T4 formulations available in the market: the tablet, the soft gel capsule and the oral solution. We review literature on the new formulations and anticipate the areas of future research. EXPERT OPINION: Failure of l-T4 treatment to reach target serum thyroid-stimulating hormone levels generally prompts the physicians to increase l-T4 daily dose. In vitro studies have shown that the soft gel capsule releases the active ingredient more consistently at varying pH than the tablet. In addition, in vivo studies have confirmed the in vitro data and have demonstrated that both the soft gel capsule and the liquid formulation are capable to solve tablet l-T4 malabsorption caused by certain drugs, bariatric surgery or coffee. These new formulations may be attractive also for patients who cannot/do not want to change their (improper) habits of l-T4 ingestion. Finally, the oral solution l-T4 could be suitable for patients who cannot swallow the solid formulations.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1517/17425247.2014.918101

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 32 references

Research works printed but not linked: 29

  1. Biondi B, 2014, Endocr Rev
  2. 10.1016/j.mcna.2012.01.002 · DOI
  3. 10.1016/j.biopha.2008.07.056 · DOI
  4. 10.1210/jc.2011-2735 · DOI · Paper page
  5. 10.1001/jama.1983.03340150087037 · DOI · Paper page
  6. 10.4061/2011/809341 · DOI
  7. 10.1210/jc.2004-2111 · DOI · Paper page
  8. 10.1111/j.1365-2036.2008.03889.x · DOI
  9. 10.2165/00003088-200443140-00006 · DOI
  10. Asik M, 2013, Endocrine
  11. 10.1111/j.1467-789X.2009.00614.x · DOI · Paper page
  12. 10.1201/b12117-31 · DOI
  13. 10.1016/j.ijcard.2008.06.022 · doi:10.1016/j.ijcard.2008.06.022
  14. 10.1172/JCI103659 · DOI · Paper page
  15. 10.1016/S0022-3476(97)70215-4 · DOI
  16. 10.1007/s11999-007-0099-x · doi:10.1007/s11999-007-0099-x
  17. 10.1097/01.pec.0000190240.81222.9a · DOI
  18. 10.1089/thy.2006.16.1047 · DOI
  19. 10.1097/MAJ.0b013e31817ee556 · DOI
  20. Torres MS, 2011, Irwin & Rippe’s intensive care medicine, 1055
  21. Benvenga S, 2012, Thyroid, 22, A50
  22. 10.1517/17425247.2012.701616 · DOI
  23. Santaguida M, 2013, Thyroid, 23, A53
  24. 10.1111/j.1360-0443.2009.02756.x · DOI
  25. 10.1055/s-0032-1329951 · DOI · Paper page
  26. 10.1111/j.1365-2885.2007.00935.x · DOI
  27. Brancato D, 2014, Endocr Pract
  28. Vita R, 2013, Thyroid, 23, A
  29. Le Couteur DG, 2004, Aust Fam Physician, 33, 777

Cited by

See all 93

Metadata

Authors
Vita, R., Fallahi, P., Antonelli, A., & Benvenga, S.
Venue
Expert Opinion on Drug Delivery
Published
2014-06-04
Volume
11
Issue
7
Pages
1103-1111
ISSN
  • 1742-5247 (ISSN-L)
  • 1744-7593
OpenAlex
W2104359662
Cited by
93
References
32
FWCI
8.38
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The administration of l-thyroxine as soft gel capsule or liquid solution. https://app.cochat.ai/papers/10.1517/17425247.2014.918101
The paper
Vita, R., Fallahi, P., Antonelli, A., & Benvenga, S. (2014). The administration of l-thyroxine as soft gel capsule or liquid solution. Expert Opinion on Drug Delivery. https://doi.org/10.1517/17425247.2014.918101

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.